Treatment of HeLa cells with the DNA damaging agent,
bleomycin
(BLM), results in the formation of a nonenzymatic 5-methylene-2-pyrrolone
histone covalent modification on lysine residues (KMP).
KMP is much more electrophilic than other N-acyllysine covalent modifications and post-translational modifications,
including N-acetyllysine (KAc). Using
histone peptides containing KMP, we show that this modification
inhibits the class I histone deacetylase, HDAC1, by reacting with
a conserved cysteine (C261) located near the active site. HDAC1 is
inhibited by histone peptides whose corresponding N-acetylated sequences are known deacetylation substrates, but not
one containing a scrambled sequence. The HDAC1 inhibitor, trichostatin
A, competes with covalent modification by the KMP-containing
peptides. HDAC1 is also covalently modified by a KMP-containing
peptide in a complex milieu. These data indicate that peptides containing
KMP are recognized by HDAC1 and are bound in the active
site. The effects on HDAC1 indicate that KMP formation
in cells may contribute to the biological effects of DNA damaging
agents, such as BLM, that form this nonenzymatic covalent modification.